Published
In this brief webinar presented by Dr. Todd Bauer, we review the benefits and limitations of DNA and RNA sequencing technologies and the impact on the care of patients with advanced non-small cell lung cancer (NSCLC).
- Category
- Oncology
Be the first to comment
Up Next
-
14:00
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
-
09:35
Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule
-
05:03
A Brief Review of DNA and RNA in Advanced NSCLC with Dr. Todd M. Bauer
-
13:36
Expert Cancer Panel: Front-line management of clinical stage I NSCLC
-
09:15
Why to Consider Using Local Treatment for Metastatic NSCLC - 2025 Lung Cancer Video Library
-
04:50
Advanced Funnel Psychology
-
19:41
Part 2: ADCs Targeting TROP2 in NSCLC: Overview and Recent Data
-
14:00
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
-
18:11
Part 1: Targeted Therapy for NSCLC: Toxicity Profile of ADCs
-
05:35
The latest NSCLC data presented at ELCC 2025
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
